<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="6724">
  <stage>Registered</stage>
  <submitdate>14/09/2017</submitdate>
  <approvaldate>14/09/2017</approvaldate>
  <nctid>NCT03297411</nctid>
  <trial_identification>
    <studytitle>Clinical Outcomes With Electroconvulsive Therapy: Insights From Computational Modelling</studytitle>
    <scientifictitle>Clinical Outcomes With Electroconvulsive Therapy: Insights From Computational Modelling</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>HC17286</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Depression</healthcondition>
  </conditions>
  <interventions>
    <interventions>Treatment: surgery - Brief Temporoparietal ECT
Treatment: surgery - Ultrabrief Temporoparietal ECT
Treatment: surgery - Brief Frontoparietal ECT
Treatment: surgery - Ultrabrief Frontoparietal ECT

Active Comparator: Brief Temporoparietal ECT - Brief Pulse Temporoparietal ECT

Active Comparator: Ultrabrief Temporoparietal ECT - Ultrabrief Pulse Temporoparietal ECT

Active Comparator: Brief Frontoparietal ECT - Brief Pulse Frontoparietal ECT

Active Comparator: Ultrabrief Frontoparietal ECT - Ultrabrief Pulse Frontoparietal ECT


Treatment: surgery: Brief Temporoparietal ECT
Electroconvulsive Therapy (Brief pulse width, Temporoparietal) The intervention in this study is different combinations of pulse width and ECT electrode placements.

Treatment: surgery: Ultrabrief Temporoparietal ECT
Electroconvulsive Therapy (Ultrabrief pulse width, Temporoparietal) The intervention in this study is different combinations of pulse width and ECT electrode placements.

Treatment: surgery: Brief Frontoparietal ECT
Electroconvulsive Therapy (Brief pulse width, Frontoparietal) The intervention in this study is different combinations of pulse width and ECT electrode placements.

Treatment: surgery: Ultrabrief Frontoparietal ECT
Electroconvulsive Therapy (Ultrabrief pulse width, Frontoparietal) The intervention in this study is different combinations of pulse width and ECT electrode placements.

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>HVLT-R - Hopkins Verbal Learning Test-Revised</outcome>
      <timepoint>Approximately 30 min after ECT treatment</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>BVMT-R - Brief Visual Memory Test-Revised</outcome>
      <timepoint>Approximately 30 min after ECT treatment</timepoint>
    </primaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Aged =18 years; right-handed

          -  DSM-5 Major Depressive Episode

          -  Prescribed with a course of ECT</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Diagnosis (as defined by DSM-V) of psychotic disorder (apart from Major Depressive
             Episode with Psychotic features), current drug or alcohol abuse or dependence;

          -  ECT treatments in last 3 months from a prior course of ECT;

          -  Score &lt;23 on the Montreal Cognitive Assessment Battery (MoCA);

          -  Past or current neurological illness or injury, medical illness which may
             significantly affect neuropsychological function;

          -  Inability to give informed consent or comply with study procedures; or

          -  Not having worked or studied in an English speaking background (to ensure validity of
             neuropsychological testing).

          -  Not be claustrophobic (if having an MRI brain scan).

          -  Not have any metal in your head or body (if having an MRI brain scan).

          -  Likely non response to RUL forms of ECT, as indicated by past non response to RUL ECT</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1>The people receiving the treatment/s</masking1>
    <masking2 />
    <masking3>The people assessing the outcomes</masking3>
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 2</phase>
    <anticipatedstartdate />
    <actualstartdate>10/10/2017</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>52</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>22/06/2022</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
    <hospital>Wesley Hospital Kogarah - Sydney</hospital>
    <postcode>2217 - Sydney</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>The University of New South Wales</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Wesley Hospital, Kogarah</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study will generate new information on how to optimise brain targets with ECT
      stimulation.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT03297411</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Colleen Loo, MBBS</name>
      <address>The University of New South Wales</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name>Feng Lin, MD</name>
      <address />
      <phone>+612 9382 8318</phone>
      <fax />
      <email>feng.lin@student.unsw.edu.au</email>
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>